Watch study for heart monitoring in lymphoma or sarcoma patients
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study uses a wearable device to monitor heart health in people treated for lymphoma or sarcoma. It aims to detect heart changes early, which may help prevent long-term heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with lymphoma or sarcoma.
- You are about to start or have completed anthracycline chemotherapy within the past year.
- You are willing to wear a device and follow study procedures for the entire study.
- You have a normal heart function (LVEF of 50% or higher) at the start.
- You do not have a history of heart failure, persistent atrial fibrillation, left bundle branch block, or a paced heartbeat.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a supervised exercise program can improve heart health in people who finished treatment for Hodgkin or aggressive non-Hodgkin lymphoma 2–5 years ago. The goal is to see if regular exercise helps your heart recover better after chemotherapy or chest radiation.
This study uses wearable heart monitors to check for heart problems during cancer treatment. Participants wear a small patch that tracks their heart rhythm, helping doctors detect issues early.
This study uses a smartwatch to monitor your activity and recovery after treatment for sarcoma or bone cancer in your leg or pelvis. It helps your care team keep track of how you're doing from home.
This study tests a wearable device to check heart and lung function during daily activities and exercise. It may help people with certain heart conditions get better monitoring without extra procedures.
This study uses wearable technology (like smartwatches) to monitor your health and quality of life while you receive treatment for blood cancers like myeloma or myelodysplastic syndromes. The goal is to help doctors better understand how blood transfusions and other supportive care affect how you feel day-to-day.
This study tests a way to adjust radiation doses for people getting chest radiation, using a wearable device to watch for heart rhythm problems. It aims to reduce the chance of irregular heartbeats after treatment.
Hear when a new Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.